ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 福島医学会
  2. Fukushima Journal of Medical Science
  3. Vol.62 (2016)

Successful therapy with tonsillectomy plus pulse therapy for the relapse of pediatric IgA nephropathy treated with multi-drugs combination therapy

https://fmu.repo.nii.ac.jp/records/2001917
https://fmu.repo.nii.ac.jp/records/2001917
ca45e6b7-c7cf-4b3e-bff5-449c6716785f
名前 / ファイル ライセンス アクション
FksmJMedSci_62_p68.pdf FksmJMedSci_62_p68.pdf (603.3 KB)
Item type デフォルトアイテムタイプ(フル)fmu(1)
公開日 2016-07-06
タイトル
タイトル Successful therapy with tonsillectomy plus pulse therapy for the relapse of pediatric IgA nephropathy treated with multi-drugs combination therapy
言語 en
作成者 Sakai, Nobuko

× Sakai, Nobuko

en Sakai, Nobuko

Search repository
Kawasaki, Yukihiko

× Kawasaki, Yukihiko

en Kawasaki, Yukihiko

Search repository
Waragai, Tomoko

× Waragai, Tomoko

en Waragai, Tomoko

Search repository
Oikawa, Tomoko

× Oikawa, Tomoko

en Oikawa, Tomoko

Search repository
Kaneko, Masatoshi

× Kaneko, Masatoshi

en Kaneko, Masatoshi

Search repository
Sato, Tomoko

× Sato, Tomoko

en Sato, Tomoko

Search repository
Suyama, Kazuhide

× Suyama, Kazuhide

en Suyama, Kazuhide

Search repository
Hosoya, Mitsuaki

× Hosoya, Mitsuaki

en Hosoya, Mitsuaki

Search repository
権利情報
権利情報 © 2016 The Fukushima Society of Medical Science
内容記述
内容記述タイプ Abstract
内容記述 Immunoglobulin A nephropathy (IgAN) is the most common form of chronic glomerulonephritis worldwide. In Japan, the treatment for use as an initial therapy was established in Guidelines for the Treatment of Childhood IgA nephropathy; however, no rescue therapy for recurrent or steroid-resistant pediatric IgAN was established. We report here a 15-year-old boy with severe IgAN, who was treated with combination therapy involving prednisolone, mizoribine, warfarin, and dilazep dihydrochloride for 2 years. The response to the combination therapy was good and both proteinuria and hematuria disappeared. The pathological findings at the second renal biopsy were improved and PSL was discontinued. However, due to nonadherence to the treatment regimen and tonsillitis, macrohematuria and an increase of proteinuria were again observed and the pathological findings at the third renal biopsy showed clear deterioration. The patient was, therefore, diagnosed with recurrent IgAN. Tonsillectomy plus methylprednisolone pulse therapy (TMP) was performed as a rescue therapy for the recurrence of severe IgAN. Both the proteinuria or hematuria subsequently disappeared, and no proteinuria or hematuria has been observed and kidney function has remained normal during a 5-year follow-up. The patient experienced no severe side effects associated with the drug regimens. In conclusion, our case suggests that TMP may be an effective and useful rescue therapy for recurrent IgAN after multi-drug combination therapy.
出版者
出版者 The Fukushima Society of Medical Science
言語
言語 eng
書誌情報 en : Fukushima Journal of Medical Science

巻 62, 号 1, p. 68-73, 発行日 2016
関連情報
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 https://doi.org/10.5387/fms.2016-3
関連情報
識別子タイプ PMID
関連識別子 27210310
関連情報
識別子タイプ ICHUSHI
関連識別子 2017326468
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
収録物識別子
収録物識別子タイプ PISSN
収録物識別子 0016-2590
収録物識別子
収録物識別子タイプ EISSN
収録物識別子 2185-4610
収録物識別子
収録物識別子タイプ NCID
収録物識別子 AA0065246X
主題
主題Scheme Other
主題 IgA nephropathy
主題
主題Scheme Other
主題 tonsillectomy plus pulse therapy
主題
主題Scheme Other
主題 recurrence
主題
主題Scheme Other
主題 multi-drugs combination therapy
主題
主題Scheme Other
主題 Mizoribine
戻る
0
views
See details
Views

Versions

Ver.1 2024-12-02 02:26:38.535879
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3